Picture B cell-4


To accelerate the time-to-market for therapeutics, leading biopharmaceutical companies are applying powerful B cell screening technologies like Cyto-Mine® that allow the highly efficient isolation of cells that produce potential therapeutic antibodies.

Download our new eBook to learn how researchers have screened and isolated rare antigen-specific B cells directly from large heterogeneous populations in just two days. By using Cyto-Mine®, researchers have overcome challenges in the antibody discovery process which are:

  • Efficiency - screen the entire cell population
  • Viability - maintain high levels of cell viability
  • Speed - reduce total workflow timelines
  • Measurement - semi-quantitative assays of antibody secretion
  • Sensitivity & specificity - detect antibodies of interest
  • Flexibility - adaptable assay design for specific needs